Company

Cipher Pharmaceuticals Inc.

Headquarters: Oakville, ON, Canada

CEO: Mr. Craig J. Mull

TSX: CPH -0.70%

Market Cap

C$202.3 Million

CAD as of July 1, 2024

US$147.3 Million

Market Cap History

Cipher Pharmaceuticals Inc. market capitalization over time

Evolution of Cipher Pharmaceuticals Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cipher Pharmaceuticals Inc.

Detailed Description

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Cipher Pharmaceuticals Inc. has the following listings and related stock indices.


Stock: TSX: CPH wb_incandescent

Stock: FSX: PHE wb_incandescent

Stock: OTC: CPHRF wb_incandescent

Details

Headquarters:

209 Oak Park Boulevard

Suite 501

Oakville, ON L6H 0M2

Canada

Phone: 905 602 5840